AI Ambient Scribe in Psychiatry

The goal of this clinical trial is to learn if an artificial intelligence (AI) tool thatlistens to appointments and drafts clinical notes can help clinicians in psychiatriccare. Researchers also want to know if the tool changes how patients experience theircare. The study includes mental health care providers (physicians,psychologists/psychotherapists, nurses, and social workers) at Psychiatrie St. Gallen andthe adult patients they see in their appointments.The main questions it aims to answer are: ‐ Does the AI tool lower the time clinicians spend writing notes? ‐ Are notes written with the AI tool as good as or better than notes written withoutit? ‐ Do patients notice a difference in their relationship with their clinician when thetool is used?Researchers will compare clinicians who use the AI tool to clinicians who keep writingnotes their usual way, before and during the intervention period, to see if writing time,note quality, and the patient‐rated therapeutic relationship differ between the twogroups.Clinicians will:Join one of two groups. One group starts using the AI tool on August 14, 2026. The othergroup keeps writing notes the usual way. Both groups will be observed until the end ofNovember 2026, with note quality evaluation completed in December 2026. Clinicians whocannot contribute to all measurements may, with their consent, remain in the study forautomated measurement of documentation time only.Patients will: ‐ Be invited to fill out a short, anonymous survey about their experience with theirclinician. ‐ Be asked to agree, in writing, that researchers may review the report from theirinitial assessment appointment.